Marston S B, Fraser I D, Huber P A
Department of Cardiac Medicine, National Heart and Lung Institute, London, United Kingdom.
J Biol Chem. 1994 Dec 23;269(51):32104-9.
We have demonstrated that caldesmon does not alter the affinity of weak binding actomyosin complexes when it inhibits actin-tropomyosin activation at physiological ratios (1 per 14 actins), and we proposed that it acts upon the strong binding complexes in the same way that troponin-tropomyosin does. We therefore compared the effect of caldesmon, caldesmon fragments, and troponin upon the interaction of the strongly bound complexes S-1.ADP, S-1.adenylyl imidodiphosphate (AMP.PNP), and N-ethylmaleimide-treated myosin subfragment-1 (NEM-S-1) with actin-tropomyosin. In 0.17 M ionic strength buffer [14C]iodoacetamide-labeled S1.ADP bound to actin-smooth muscle tropomyosin with no evidence of cooperativity; Kd = 0.8 +/- 0.3 microM (n = 5). Inhibitory concentrations of sheep aorta caldesmon or rabbit skeletal muscle troponin made the binding highly cooperative. At low levels of saturation the apparent Kd was 10-40 microM with 10 microM caldesmon and 8-20 microM with 6 microM troponin; at > 50% saturation the binding was indistinguishable from actin-tropomyosin alone. A similar result was obtained for the binding of [14C]iodoacetamide-labeled S-1.AMP.PNP to actin-smooth muscle tropomyosin at 0.03 M ionic strength (Kd = 0.47 +/- 0.05 microM). Binding was slightly cooperative and became highly cooperative in the presence of inhibitory concentrations of troponin, caldesmon, and the human caldesmon fragments H7 (amino acids 622-767) and H9 (amino acids 726-793). We conclude that caldesmon and troponin both act as allosteric effectors of the "on"/"off" equilibrium of actin-tropomyosin. 0.1 NEM-S-1/actin potentiated actin-smooth muscle tropomyosin activation of myosin MgATPase 7-fold at 0.03 M ionic strength. Caldesmon inhibited the ATPase in the presence and absence of 0.5 microM NEM-S-1. NEM-S-1 reactivated actin-tropomyosin, which had been inhibited by troponin, caldesmon, H7, or H9. This is compatible with opposing effects of NEM-S-1 and caldesmon or troponin upon the actin-tropomyosin on/off equilibrium.
我们已经证明,在生理比例(每14个肌动蛋白中有1个)下,钙调蛋白抑制肌动蛋白 - 原肌球蛋白激活时,不会改变弱结合肌动球蛋白复合物的亲和力,并且我们提出它对强结合复合物的作用方式与肌钙蛋白 - 原肌球蛋白相同。因此,我们比较了钙调蛋白、钙调蛋白片段和肌钙蛋白对强结合复合物S-1.ADP、S-1.腺苷酰亚胺二磷酸(AMP.PNP)以及N-乙基马来酰亚胺处理的肌球蛋白亚片段-1(NEM-S-1)与肌动蛋白 - 原肌球蛋白相互作用的影响。在0.17M离子强度缓冲液中,[14C]碘乙酰胺标记的S1.ADP与肌动蛋白 - 平滑肌原肌球蛋白结合,没有协同作用的证据;解离常数Kd = 0.8±0.3微摩尔(n = 5)。绵羊主动脉钙调蛋白或兔骨骼肌肌钙蛋白的抑制浓度使结合具有高度协同性。在低饱和度水平下,10微摩尔钙调蛋白时表观Kd为10 - 40微摩尔,6微摩尔肌钙蛋白时为8 - 20微摩尔;在饱和度>50%时,结合与单独的肌动蛋白 - 原肌球蛋白无法区分。在0.03M离子强度下,[14C]碘乙酰胺标记的S-1.AMP.PNP与肌动蛋白 - 平滑肌原肌球蛋白结合也得到了类似结果(Kd = 0.47±0.05微摩尔)。结合略有协同性,在存在抑制浓度的肌钙蛋白、钙调蛋白以及人钙调蛋白片段H7(氨基酸622 - 767)和H9(氨基酸726 - 793)时变得高度协同。我们得出结论,钙调蛋白和肌钙蛋白均作为肌动蛋白 - 原肌球蛋白“开”/“关”平衡的变构效应器。在0.03M离子强度下,0.1NEM-S-1/肌动蛋白使肌球蛋白MgATPase的肌动蛋白 - 平滑肌原肌球蛋白激活增强了7倍。在存在和不存在0.5微摩尔NEM-S-1的情况下,钙调蛋白均抑制ATP酶。NEM-S-1使已被肌钙蛋白、钙调蛋白、H7或H9抑制的肌动蛋白 - 原肌球蛋白重新激活。这与NEM-S-1和钙调蛋白或肌钙蛋白对肌动蛋白 - 原肌球蛋白开/关平衡的相反作用相符。